Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial ribosomal subunits are the two major structural and functional components (30S small subunit and 50S large subunit) of the bacterial ribosome (70S), a cytoplasmic macromolecular machine that catalyzes protein synthesis in all bacteria[1][2][3][4][5][6][7]. The 30S subunit, containing 16S rRNA and ~21 proteins, is responsible for mRNA binding and decoding, while the 50S subunit, composed of 23S and 5S rRNAs and ~31 proteins, catalyzes peptide bond formation and provides the exit tunnel for nascent proteins[1][3][5][6]. These subunits are essential for bacterial viability, serving as central therapeutic targets for multiple antibiotic classes that exploit structural and functional differences between bacterial and eukaryotic ribosomes to inhibit bacterial growth selectively[3][5][6]. Mutations in these subunits are key mechanisms for antibiotic resistance[3], and their similarity to mitochondrial ribosomes underlies some antibiotic side effects[6].\nNote:\n- *is_incorrect: true* because "Bacterial ribosomal subunits" is plural and refers to a complex, not a single canonical target; information should, where possible, refer to either the "30S ribosomal subunit" or "50S ribosomal subunit" specifically for greater precision, but the above structure summarizes the commonly referenced collective target of this class by antibiotics.\n- The ribosome is not a classic "receptor" or single protein, but is a validated antibacterial drug target[3][5][6].
Inhibition of mRNA translation (blocking mRNA decoding or tRNA binding)\nInhibition of peptide bond formation (peptidyl transferase center)\nDisruption of ribosome assembly or function
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial ribosomal subunit.